In addition, it was also demonstrated to serve as a predictor of responses to treatment, as a significantly larger proportion of ICOS+ Tregs and skewed type 2 responses were observed in MTX-non-responsive RA patients (132). Here, ICOS is linked to rheumatoid arthritis.